KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Minority Interest (2016 - 2025)

Merck (MRK) has disclosed Minority Interest for 17 consecutive years, with $57.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Minority Interest fell 1.72% to $57.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $57.0 million, a 1.72% decrease, with the full-year FY2024 number at $59.0 million, up 9.26% from a year prior.
  • Minority Interest was $57.0 million for Q3 2025 at Merck, down from $67.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $94.0 million in Q1 2021 to a low of $49.0 million in Q2 2023.
  • A 5-year average of $66.7 million and a median of $66.0 million in 2022 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: crashed 34.67% in 2023, then soared 34.69% in 2024.
  • Merck's Minority Interest stood at $73.0 million in 2021, then fell by 8.22% to $67.0 million in 2022, then decreased by 19.4% to $54.0 million in 2023, then grew by 9.26% to $59.0 million in 2024, then decreased by 3.39% to $57.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Minority Interest are $57.0 million (Q3 2025), $67.0 million (Q2 2025), and $65.0 million (Q1 2025).